Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees-Reference-Cited by-同舟云学术

Distinct Helper T Cell Type 1 and 2 Responses Associated With Malaria Protection and Risk in RTS,S/AS01E Vaccinees

Published:2017-05-13 Issue:5 Volume:65 Page:746-755
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Moncunill Gemma¹²,Mpina Maxmillian³,Nhabomba Augusto J²,Aguilar Ruth¹,Ayestaran Aintzane¹,Sanz Héctor¹,Campo Joseph J¹²,Jairoce Chenjerai²,Barrios Diana¹,Dong Yan⁴,Díez-Padrisa Núria¹,Fernandes José F⁵,Abdulla Salim⁶,Sacarlal Jahit²⁷,Williams Nana A¹,Harezlak Jaroslaw⁴,Mordmüller Benjamin⁵⁸,Agnandji Selidji T⁵,Aponte John J¹²,Daubenberger Claudia⁹¹⁰,Valim Clarissa¹¹¹²,Dobaño Carlota¹²

Affiliation:

1. ISGlobal, Barcelona Centre for International Health Research, Hospital Clínic–Universitat de Barcelona, Catalonia, Spain;

2. Centro de Investigação em Saúde de Manhiça, Maputo, Mozambique;

3. Ifakara Health Institute, Bagamoyo Research and Training Centre, Tanzania;

4. Department of Epidemiology and Biostatistics, School of Public Health, Indiana University, Bloomington;

5. Centre de Recherches Médicales de Lambaréné, Albert Schweitzer Hospital, Gabon;

6. Ifakara Health Institute, Dar es Salaam, Tanzania;

7. Faculdade de Medicina da Universidade Eduardo Mondlane, Maputo, Mozambique;

8. Institute of Tropical Medicine, German Center for Infection Research, University of Tübingen, Germany;

9. Swiss Tropical and Public Health Institute, Basel, and

10. University of Basel, Switzerland;

11. Department of Osteopathic Medical Specialties, Michigan State University, East Lansing; and

12. Department of Immunology and Infectious Diseases, Harvard T. H. Chan School of Public Health, Boston, Massachusetts

Funder

National Institutes of Health

National Institute of Allergy and Infectious Diseases

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/65/5/746/24266391/cix429.pdf

Reference36 articles.

1. A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants;RTS,S Clinical Trials Partnership;N Engl J Med,2012

2. First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children;Agnandji;N Engl J Med,2011

3. Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial;RTS,S Clinical Trials Partnership;Lancet,2015

4. Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique;Barbosa;Infect Immun,2009

5. Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D);Agnandji;PLoS One,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial;The Lancet Microbe;2024-08

2. An Adjuvanted Vaccine-Induced Pathogenesis Following Influenza Virus Infection;Vaccines;2024-05-23

3. Background malaria incidence and parasitemia during the three-dose RTS,S/AS01 vaccination series do not reduce magnitude of antibody response nor efficacy against the first case of malaria;BMC Infectious Diseases;2023-10-23

4. Immunological factors linked to geographical variation in vaccine responses;Nature Reviews Immunology;2023-09-28

5. The RTS,S malaria vaccine: Current impact and foundation for the future;Science Translational Medicine;2022-11-16